chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a Licensed Practical Nurse referring to a patient of unknown age and gender. Medical history and concurrent condition of the patient was not reported. On 22-OCT-2014 the patient was vaccinated with one dose of VAQTA (lot number J015882, expiration date 22-OCT-2015, dose and route were unknown) which underwent an unsupported temperature excursion. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Feeling achy; Hot to the touch at the injection site; Itchy at the injection site; Headache; Swollen lymph nodes in the arm at the injection site; Big red spot on the arm close to the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Feeling achy), VACCINATION SITE WARMTH (Hot to the touch at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site), VACCINATION SITE LYMPHADENOPATHY (Swollen lymph nodes in the arm at the injection site) and VACCINATION SITE ERYTHEMA (Big red spot on the arm close to the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Swollen lymph nodes in the arm at the injection site) and VACCINATION SITE ERYTHEMA (Big red spot on the arm close to the injection site). On 08-Mar-2021, the patient experienced PAIN (Feeling achy), VACCINATION SITE WARMTH (Hot to the touch at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site) and HEADACHE (Headache). On 08-Mar-2021, VACCINATION SITE ERYTHEMA (Big red spot on the arm close to the injection site) had resolved. At the time of the report, PAIN (Feeling achy), VACCINATION SITE WARMTH (Hot to the touch at the injection site), VACCINATION SITE PRURITUS (Itchy at the injection site), VACCINATION SITE LYMPHADENOPATHY (Swollen lymph nodes in the arm at the injection site) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Presented with rash, low grade fever approximately 11 days after receiving Proquad.  Diagnosed with atypical measles.  Was treated with over the counter Benadryl.
Headache since time of infection that still persists; Headache since time of infection that still persists; sinus headache; Extremely fatigue; DOSE 6 (BOOSTER); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 16Sep2023 at 11:00 as dose 6 (booster), single (Lot number: HH4595) at the age of 66 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies:Pcn" (unspecified if ongoing). Concomitant medication(s) included: NIACINAMIDE; ATORVASTIN; METOPROLOL. Vaccination history included: Covid-19 vaccine (DOSE 5; MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 4; MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 3; MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 Immunization; Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 16Sep2023 at 11:00, outcome "unknown", described as "DOSE 6 (BOOSTER)"; FATIGUE (non-serious) with onset 16Sep2023 at 11:00, outcome "not recovered", described as "Extremely fatigue"; INFECTION (non-serious), HEADACHE (non-serious) all with onset 16Sep2023 at 11:00, outcome "not recovered" and all described as "Headache since time of infection that still persists"; SINUS HEADACHE (non-serious) with onset 16Sep2023 at 11:00, outcome "not recovered". Therapeutic measures were not taken as a result of infection, headache, sinus headache, fatigue.
Approximately two hrs after vaccination I began having ringing in the ears and it hasn't gone away.
Hot across the chest area, given benadrily 50mg orally and discharged @ 12:32pm with symptoms relieved.
After receiving his first Covid vaccine, mom noticed a very small bluish/black dot at the injection site. It was not swollen or painful. We were using a different brand needles than our usual so unsure if the spot was left from the needle or the vaccine itself.
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old male patient received BNT162b2 (BNT162B2), on 24Feb2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 15Mar2021 as dose 2, single (Batch/Lot number: unknown), in left arm, on 31Aug2021 as dose 3 (booster) , single (Batch/Lot number: unknown), in left arm and on 30Mar2022 as dose 4 (booster) , single (Batch/Lot number: unknown) at the age of 65 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing), notes: All well controlled with medicine; "high blood pressure" (unspecified if ongoing), notes: All well controlled with medicine; "high cholesterol" (unspecified if ongoing), notes: All well controlled with medicine; "hypothyroidism" (unspecified if ongoing), notes: All well controlled with medicine. Concomitant medication(s) included: ASPIRIN [ACETYLSALICYLIC ACID]; LOSARTAN; ROSUVASTATIN; LEVOTHYROXINE; INSULIN; VITAMIN B COMPLEX; VITAMIN D [VITAMIN D NOS]. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: Indication: Covid-19 treatment; (Jun2022) Negative. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical information:Rebound Covid case 8 days after tested negative following Paxlovid treatment  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information has been received from a physician concerning a male patient who was a physician as well, vaccinated sometime in august 2008 with a 0.65ml dose of ZOSTERVAX. Subsequently the patient experienced hot flashes and aches and pains on face 2 weeks after vaccination. The patient sought medical attention. Outcome was unknown additional information has been requested.
He had a bad fever upon waking on 11/16/2012 AND his arm where he was injected was VERY hot to the touch. I assumed it would go away, but its still hot, minus the fever now. I believe he ALSO had a seizure and fever after one of his other shots he got when he was 2 yrs old & took an ambulance ride to the E.R..although I never reported THAT incident. I will be taking him to the E.R today to have his arm looked at for the shot he got 2 days ago.
I do not know which flu shot I received.  My symptoms are as follows.  I received both shots about a half inch apart on my left arm.  There was a sensation going up my neck on the left side and across my upper chest for a few seconds.  I experienced fatigue for 2 days.  My upper left arm has been swollen for 3 days and is slowly getting better.  It looked like a large, red hive around the shot area.  The red, swollen area is hot to the touch.  I had soreness at the shot site for 2 days.  I have used Cortaid on the site the last day or so and it seems to be improving.
Nausea; Violent vomiting; Chills; Low grade fever; Body aches; Headache; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 16-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 07Nov2022 at 16:00 as dose 4 (booster), single (Lot number: GJ3277) at the age of 16 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Polyarthritis" (unspecified if ongoing). Concomitant medication(s) included: HUMIRA; METHOTREXATE; FOLIC ACID. Vaccination history included: Covid-19 vaccine (Dose:01, Manufacturer: Unknown), for COVID-19 Immunization; Covid-19 vaccine (Dose:02, Manufacturer: Unknown), for COVID-19 Immunization; Covid-19 vaccine (Dose:03, Manufacturer: Unknown), for COVID-19 Immunization. The following information was reported: PAIN (non-serious) with onset 08Nov2022 at 06:00, outcome "recovered" (2022), described as "Body aches"; CHILLS (non-serious) with onset 08Nov2022 at 06:00, outcome "recovered" (2022); HEADACHE (non-serious) with onset 08Nov2022 at 06:00, outcome "recovered" (2022); PYREXIA (non-serious) with onset 08Nov2022 at 06:00, outcome "recovered" (2022), described as "Low grade fever"; NAUSEA (non-serious) with onset 08Nov2022 at 06:00, outcome "recovered" (2022); VOMITING (non-serious) with onset 08Nov2022 at 06:00, outcome "recovered" (2022), described as "Violent vomiting". Therapeutic measures were not taken as a result of nausea, vomiting, chills, pyrexia, pain, headache.  Additional information: No known allergy reported. Dose received: More than 3. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store.  Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient not diagnosed with COVID-19. Since the vaccination, has the patient been not tested for COVID-19. Device Date: 04Dec2022.  No follow-up attempts are possible. No further information is expected.
As with my second shot I had high fever (103.7), myalgias and headache starting about 12 hours after the shot and lasting 24 hours. 24 hours after the shot-I noticed what I thought was severe heartburn (I do not have heartburn normally-only during my first pregnancy 11 years ago). I tried Tums-which didn?t work-it was night so propped myself on pillows-and only found comfort by leaning forward and sleeping upright. I was otherwise febrile and not feeling good so forgot about it. Then my sister had the 3rs Pfizer shot and called me the night after she did saying she had awful heartburn-and wondering if I?d had this side effect. We decided to report it, since it was two of us. The symptom lasted maybes 8-10 hours and then completely resolved.
Received HPV vaccine in her left arm on 05/22/17 and at night her arm looked burned. It was multiple shades of red, skin was raised and it looked bruised and blistered. Skin is no longer raised today and discoloration has faded some but it is still multiple shades with bruising above it and a blister where the needle went in.
Red, warm, tender, swollen upper arm with pain radiating to lt axilla and chest. ibuprofen and heat.
Upon arising June 2nd was unable to use my right arm.. it then affected the left shoulder and down to both hips discovered at a physical through blood work and diagnosed with PMR
Migraine (similar to the one I experienced when I had COVID in July/August) began a few minutes after the shot was adminstered. It started mild but continued to get worse. It started to get better the following night (12/16/2020) and was gone by the time I went to bed. The day after I got the shot I felt extremely nauseous when I woke up. It was bad enough that I missed two days of work. This lasted for several days and only just went away completely today (12/21/2020. I took ondansetron to treat the nausea. I felt lightheaded and fatigued around the same timeframe as the nausea, but did not use anything treat either. I am not a regular caffeine drinker but tried it every day to help combat the fatigue. It did nothing to help and made me anxious. I still do not feel great but I am well enough to work.
lymph node swelling on collar bone; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 05Mar2021 (Batch/Lot number: unknown) as DOSE 1, SINGLE for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 15Mar2021, outcome "unknown", described as "lymph node swelling on collar bone".  No follow-up attempts are possible. No further information is expected.
Woke up with severe bodyaches worse on injection site with fever of 100.6 degrees farenheit.
felt pretty rotten; Aches; Chills; Horrible headaches; This case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling bad, pain, chills and headache. On an unknown date, the outcome of the feeling bad, pain, chills and headache were recovered/resolved.   It was unknown if the reporter considered the feeling bad, pain, chills and headache to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR015205  Additional details were provided as follows: The patient self-reported this report. The age at vaccination was not reported. The patient received a shot and especially the 2nd shot was pretty yucky. The patient felt pretty rotten for about 4 to 5 days.  The patient had aches, chills and horrible headaches. The reporter was sure not as bad as case of shingles. The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR015205:Same reporter
Walks with a walker because is without stability to walk; Rash in both legs; A spontaneous report was received from a consumer (patient) who is a 85-year-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rash in both legs (rash) and the use of a walker because is without stability to walk (balance disorder).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 27-Jan-2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection. On 22-Feb-2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 08-Mar-2021, the patient experienced a rash in both legs and walked with a walker because was without stability to walk.  No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events is not applicable.  The events of rash in both legs (rash), walks with a walker because is without stability to walk (balance disorder) were unresolved.  The reporter did not provide an assessment for the events rash in both legs (rash), walks with a walker because is without stability to walk (balance disorder).; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
For two or three day after the vaccine, I had pains in my arm where it was given, but they went away. About a week after, I started having more intense pain at the site that radiated to my shoulder, back, and arm. It has been almost a month and my arm still hurts at the spot where it was given when I lift, carry, or move it outside a small ROM.
POSITIVE NASAL SWAB FLU TEST; A spontaneous report has been received from a health professional. The report concerns a female patient (age not provided) of Unknown ethnic origin.    No medical history was reported. The following demography was reported for the patient's parent:   Sex: Unknown    No concomitant products were reported.    The patient received Flumist Quadrivalent (influenza virus vaccine live, intranasal) (batch number Unknown) 0.2 ml once/single administration, via nasal route, for flu vaccine on 09-NOV-2020.     On 11-NOV-2020, the patient experienced positive nasal swab flu test (preferred term: Influenza).     It is unknown if any action was taken with Flumist Quadrivalent (influenza virus vaccine live, intranasal).     The outcome of the event was unknown.    The event was considered non-serious.     Laboratory values are available.
1st day unable to get out of bed, not enough strength to sit up, little pain, nosebleed, increased pulse rate, no food : 2nd day pulse rate up and down, no food generally no pain: 3 rd feeling better large arm rash , about 10 inches including in injection site  :4th day, rash still visible, light itching, feeling better, have eaten.  believe i will recover, approximately 7 days
paraesthesias bilateral arms upon awakening frontal/temporal headache, lower back pain, thighs and arms numb. -All self resolved with in hours
patient reported increased soreness in right arm and shoulder on 12/20/2022 from imz on 10/22/2022
Havrix pedriatric administered to adult; Havrix pedriatric administered to adult; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a adult male patient who received HAV (Havrix 720) (batch number EP47E, expiry date 6th February 2023) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 20th October 2022, the patient received Havrix 720 and Havrix Pre-Filled Syringe Device. On 20th October 2022, unknown after receiving Havrix 720 and Havrix Pre-Filled Syringe Device, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 20-Oct-2022 Reporter's comment: No additional patient demographics was available from the health care professional at the time of call. The reporter consented to follow-up. Additional supportive information: An adult patient received pediatric dose of Havrix, which led to underdose and adult use of a child product.
On 01/22/2022 I started having severe cough, fatigue, headache, nauseous, and I generally felt bad. I went to the doctor on 01/24/2022 and tested positive. Then on the 01/26/2022 I went to the Emergency room because I had trouble breathing and was coughing. On the 27th, the hospital also tested me, and I was positive, and I was put on the ventilator for a week. When I was taken off it got worse so I was put back on for over a week. After they took me out of ICU, I was not mobile. I could not move any part of my body and was completely immobile. They took me to a rehab on 02/19/2022 I had total immobility. Around 03/28/2022 I finally got to where I could stand up on parallel bars for about 30 seconds. On 04/15/2022 I was discharged from rehab and able to walk but doing outpatient care until 05/12/2022. Both inpatient and outpatient rehab could not believe how fast I could regain my ability to be mobile. I overall feel absolutely terrible. I am still walking with a walker. I get winded quickly and I don't have the strength I used to have. I lost a lot of muscle mass. I weighed 265lbs I was 207lbs upon discharge but now 225. I do have a problem with my right hand and arm is now affected with because I was kept on my right side, and I cannot feel my pinky or ring finger and numb from elbow to fingers. I believe it is from not being moved much and kept on my right side. They performed so many tests but I am not sure what they did.
pt became pale, hands clutched to sternum head back eyes open; no response to verbal stimuli;
2/17, admitted 2 days after covid vaccine with syncope/rhabdo. Patient admitted for mild rhabdomyolysis after a noncardiac syncopal episode that was thought to be related to recent Covid-19 vaccination. Troponin is elevated 0.25, lactate is elevated at 5.5.  BMP shows elevation in glucose and BUN.  PT/INR is elevated.  VBG is unremarkable.  CBC shows a macrocytic hyperchromic anemia.  Patient's CK came back significant elevated likely indicating rhabdomyolysis. Admitted for cardiology consult. Patient was treated aggressively with IV fluids.  Patient had multiple reevaluations given his history of congestive heart failure. After evaluation- not sure what caused the patient to collapse, but the etiology does not appear to have been cardiac.  The patient thinks it may have been due to a reaction to the COVID vaccine.
Intermittent bouts of paresthesia from the left shoulder to the left elbow but most often over the deltoid. It felt like icy hot cream on the skin; This is a spontaneous report from a contactable nurse, the patient. A 60-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 01Apr2021 at 09:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, vitamin d deficiency, vitamin b12 deficiency, coeliac disease (possible celiac), arthritis. The patient allergic to penicillin, adhesive tape and deodorant allergy (an unknown ingredient in sure deodorant). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN) and estradiol (MANUFACTURER UNKNOWN), all taken for unknown indication for unknown date and unknown if ongoing. On 01Apr2021 at 10:00, 1 hour after the vaccination, the patient had intermittent bouts of paraesthesia from the left shoulder to the left elbow but most often over the deltoid. It felt like "icy" hot cream on the skin. It lasted anywhere from 5 minutes to a couple hours at that time and occurring a few times per day. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event intermittent bouts of paresthesia from the left shoulder to the left elbow was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
About 2 days after my second shot of the Pfizer Vaccine, I experienced a rash on the back of my left shoulder and arm, not far from the injection site. It was around the back side of my upper arm and shoulder/arm pit area.  Rash had a hives like look (red bumps) and only on my left side. I also experienced a similar, but smaller rash on the back side of my right knee on day 3 after my second dose. These rashes were very itchy. It is now day 4 post second shot and the rash is still present but appears to be lessening a bit.
After administering the vaccine, patient lost consciouness and turned red. Since it felt like an allergic reaction, administered Epipen and the patient regained conciousness in a few minutes. Paramdeics came and check and the vitals was normal. There is a possibilty the patient had panic attack.
Beginning 10/09/10 pt began w/sx's of muscle aches & pain; Nausea x2 days
Initial injection site pain lasted for a day or so, went away, and now arm is sore again at injection site.